Semi-Annual Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7553802

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-289,731,000 JPY
-123,641,000 JPY
-123,641,000 JPY
-123,641,000 JPY
-258,767,000 JPY
-123,641,000 JPY
Comprehensive income
-289,731,000 JPY
-258,767,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-289,731,000 JPY
-258,767,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.